Latest

Touchlight wins CPHI Pharma Award for cell-free DNA manufacturing

The UK biotech's Doggybone DNA platform won the Innovation Catalyst category at CPHI Milan 2026, recognising its potential to support scalable DNA production for genetic medicines

Find out more
Touchlight wins CPHI Pharma Award for cell-free DNA manufacturing

You need to be a subscriber to read this article.
Click here to find out more.
AI agents target drug safety, protein discovery and secure health data analysis

AI agents target drug safety, protein discovery and secure health data analysis

Three companies serving the life sciences sector have unveiled new artificial intelligence tools spanning safety...
See more
Abolis launches microbial intelligence platform to optimise bioprocess development

Abolis launches microbial intelligence platform to optimise bioprocess development

The company has launched MINE, a multi-omics platform designed to help pharmaceutical and other industrial R&D teams identify microbial production pathways, prioritise experiments and support fermentation process optimisation and scale-up
Cochrane review links pharma payments to prescribing practices

Cochrane review links pharma payments to prescribing practices

A Cochrane review of 93 studies has linked pharmaceutical industry promotional activities with less appropriate prescribing and higher prescription costs, prompting renewed calls for stronger conflict-of-interest policies and greater transparency in the UK
Rethinking the route to first-in-human studies

Rethinking the route to first-in-human studies

For sponsors, development activities and fragmented clinical supply can slow the path from candidate selection to first-in-human (FIH) dosing. A more integrated approach can reduce avoidable complexity while preserving the flexibility needed for early clinical programmes
Ofichem acquires US drug substance CDMO Kinentia Biosciences to expand transatlantic network

Ofichem acquires US drug substance CDMO Kinentia Biosciences to expand transatlantic network

The company has agreed to acquire New York-based Kinentia Biosciences, expanding its US presence and combining Kinentia’s early-stage development expertise with Ofichem’s European drug substance development and GMP manufacturing capabilities
Charles River and Autolomous launch Apollo Orchestrate LES to digitalise biologics QC testing workflow

Charles River and Autolomous launch Apollo Orchestrate LES to digitalise biologics QC testing workflow

The autoloMATE-powered platform connects sample submission, laboratory execution and review into a single digital workflow across Charles River's North American and European Biologics Testing Solutions sites — replacing paper-based processes to accelerate client results
CPHI Pharma Awards 2026 recognise Touchlight, SeraNovo and Almac among fifteen category winners in Milan

CPHI Pharma Awards 2026 recognise Touchlight, SeraNovo and Almac among fifteen category winners in Milan

Touchlight's dbDNA platform took Innovation Catalyst, SeraNovo's NanoGlass oral formulation won Finished Formulation and Almac Clinical Services claimed Supply Chain Excellence — with BMS's Emma Charles named Woman of the Year
ASA bans first weight loss pill ads

ASA bans first weight loss pill ads

The UK's advertising watchdog has ruled against several companies advertising oral GLP-1 weight loss medications to the UK public, working with the MHRA to ensure compliance and "protect the public"
From Indonesia to the world: support Beta Pharmacon’s manufacturing excellence with GEA granulation technology

From Indonesia to the world: support Beta Pharmacon’s manufacturing excellence with GEA granulation technology

By integrating GEA granulation technology into its new facility, Beta Pharmacon has enhanced process control, reinforced its commitment to regulatory compliance, and secured GMP and USP qualifications to supply essential micronutrient supplements

More stories

Research & Development
Stablepharma doses first participant in Phase IIb trial of fridge-free tetanus-diphtheria vaccine

Stablepharma doses first participant in Phase IIb trial of fridge-free tetanus-diphtheria vaccine

The 160-person non-inferiority study is the final development step for the StablevaX-reformulated vaccine SPVX02, before commercialisation of a cold-chain-independent alternative to Tetadif
Sustainability
CPHI Milan's inaugural Sustainability Summit brings 300+ companies together to tackle pharma's sustainability challenges

CPHI Milan's inaugural Sustainability Summit brings 300+ companies together to tackle pharma's sustainability challenges

The two-day programme addresses practical barriers to sustainable procurement, manufacturing and packaging — with hackathon-style sessions and cross-industry collaboration designed to move beyond targets into measurable operational action
Manufacturing
Orano Med inaugurates Europe's first industrial-scale lead-212 radioligand therapy facility

Orano Med inaugurates Europe's first industrial-scale lead-212 radioligand therapy facility

The €29m ATLab site will target up to 10,000 doses annually and its two-hour proximity to major European airports meets the critical 24-hour production-to-administration window imposed by lead-212's 10.6-hour half-life
Manufacturing
Catalent launches ten-month gene-to-drug substance programme for complex biologics

Catalent launches ten-month gene-to-drug substance programme for complex biologics

The accelerated pathway extends the CDMO's Rapid Antibody framework to bispecifics and next-generation formats — targeting master cell bank release by month seven and bulk drug substance lot release by month ten
Finance
Bayer invests $2.2bn in new US pharmaceutical manufacturing site

Bayer invests $2.2bn in new US pharmaceutical manufacturing site

Bayer will build a new modular pharmaceutical manufacturing campus in New Albany, Ohio, with drug substance production expected to begin in 2031
You need to be a subscriber to read this article.
Click here to find out more.
Analysis
Standardising cell-based potency assays for biologics lot release: the case for cryopreserved ready-to-use cell systems (part II)

Standardising cell-based potency assays for biologics lot release: the case for cryopreserved ready-to-use cell systems (part II)

Standardised cell systems can reduce biological variability, but robust potency testing must also demonstrate accuracy, precision and linearity. ICH Q2(R2) provides the framework to establish this analytical confidence
Ingredients
C2 Pharma launches brinzolamide ophthalmic API

C2 Pharma launches brinzolamide ophthalmic API

C2 Pharma has added brinzolamide to its ophthalmic API portfolio following completion of process validation and submission of a US Drug Master File
You need to be a subscriber to read this article.
Click here to find out more.
Analysis
Standardising cell-based potency assays for biologics lot release: the case for cryopreserved ready-to-use cell systems (part I)

Standardising cell-based potency assays for biologics lot release: the case for cryopreserved ready-to-use cell systems (part I)

As biologics become increasingly complex, demonstrating consistent biological activity at lot release is essential. Yet the cell-based assays used to measure potency introduce significant challenges in standardisation, reproducibility and regulatory compliance
Ingredients
dsm-firmenich launches Biond pharmaceutical-grade vitamin portfolio for cell culture and biologics manufacturing

dsm-firmenich launches Biond pharmaceutical-grade vitamin portfolio for cell culture and biologics manufacturing

The range targets critical metabolic pathways supporting cell growth, viability and protein expression — available globally through Brenntag's BYPHAR distribution network ahead of its CPHI Milan debut
Regulatory
FDA warns Fresenius Kabi over sterile manufacturing violations

FDA warns Fresenius Kabi over sterile manufacturing violations

The agency has cited serious CGMP deficiencies at Fresenius Kabi’s Melrose Park facility, including failures involving aseptic processing, investigations, bioburden controls and visual inspection — even finding hair in some products
Drug Delivery
Bespak and Upperton partner to deliver integrated nasal drug-device combination product development pathway

Bespak and Upperton partner to deliver integrated nasal drug-device combination product development pathway

The collaboration merges Bespak's nasal device portfolio with Upperton's formulation and clinical manufacturing expertise, supporting liquid, soft mist and dry powder formats as CNS and nose-to-brain delivery applications accelerate

Sponsor Promoted Content

Your checkweigher is now a GMP data system — are you treating it like one?

Your checkweigher is now a GMP data system — are you treating it like one?

The weighing mechanism may be familiar. The regulatory expectations around the data it creates are becoming much harder to ignore.
Step into cognitive manufacturing: Welcoming you to Booth S-1720

Step into cognitive manufacturing: Welcoming you to Booth S-1720

At Pack Expo 2026, IMA Group will showcase its latest innovations in processing, packaging, end-of-line, automation, as well as digital solutions and customer services...
Xelia and Hisun sign strategic global multiple-API partnership

Xelia and Hisun sign strategic global multiple-API partnership

Long-standing joint venture partners expand collaboration, moving beyond anti-infective APIs into diversified therapeutic areas, including cardiovascular and oncology
Anton Paar launches new UNHT series for next-generation nanoindentation

Anton Paar launches new UNHT series for next-generation nanoindentation

Anton Paar introduces the new UNHT Series, a new generation of nanoindentation systems designed to deliver reliable results, faster workflows, and greater versatility...
Indena to showcase its integrated European platform for HPAPIs and complex molecules at CPHI Milan 2026

Indena to showcase its integrated European platform for HPAPIs and complex molecules at CPHI Milan 2026

The leading unit CDMO will highlight breakthroughs in ADC payloads, ultra-high containment spray drying, and its strategic QS-21 partnership
Patented device reinvents Solid Phase Extraction

Patented device reinvents Solid Phase Extraction

Biotech Fluidics announce SPEedy - a device that provides an effortless way to perform Solid Phase Extraction (SPE) sample preparation procedures without need of an...
Why early notified-body engagement matters for combination product success (VIDEO)

Why early notified-body engagement matters for combination product success (VIDEO)

Learn why early notified-body engagement is critical for combination products, including design rationale, risk controls, validation evidence and traceable documentation...
Lonza advances aseptic spray drying for high-dose biologics

Lonza advances aseptic spray drying for high-dose biologics

This new technology platform addresses stability, concentration, and delivery challenges in biologics, including new modalities
Piramal Pharma receives Ontario investment for API site

Piramal Pharma receives Ontario investment for API site

Piramal Pharma Solutions (PPS) is to invest more than $5.3m in upgrading its drug substance manufacturing site in Aurora, Canada, supported by a $1.75m investment from the...
Piramal Pharma Solutions and NP2 to complete cyclophosphamide development phase next month

Piramal Pharma Solutions and NP2 to complete cyclophosphamide development phase next month

Piramal Pharma Solutions (“PPS”), a leading global Contract Development and Manufacturing Organisation (CDMO) and part of Piramal Pharma Ltd. (“PPL”) (NSE:...
Quotient Sciences and Acesion Pharma collaborate on AI-enhanced formulation development

Quotient Sciences and Acesion Pharma collaborate on AI-enhanced formulation development

New AI-enhanced solution helps identify promising drug formulations, compressing early clinical decision-making for new treatments
Faller Packaging unveils new look and complex packaging solutions at CPhI 2026

Faller Packaging unveils new look and complex packaging solutions at CPhI 2026

At Booth 11F93 in Hall 11, the company will not only be showcasing its new look, it will also present solutions for sensitive primary products such as auto-injectors,...

Featured companies

CI Precision specialises in the design and manufacture of precision weighing systems for quality assurance in the pharmaceutical manufacturing industry. At Biotech Fluidics, our aim is to help you make your analytical work more effective and reliable. Anton Paar understands the need for completely traceable results and supports customers with a qualification and validation package following the 4Q model which fulfills the... PCI Pharma Services: Your bridge between life-changing therapies and patients.
See more

Resource Centre

Latest Media See all

From powder to granules: a deep dive into wet granulation methods - WEBINAR NOW ON DEMAND

From powder to granules: a deep dive into wet granulation methods - WEBINAR NOW ON DEMAND

From powder to granules: a deep dive into wet granulation methods - WEBINAR NOW ON DEMAND
Manufacturing Chemist Stand Side with GEA and Hovione

Manufacturing Chemist Stand Side with GEA and Hovione

Manufacturing Chemist Stand Side with GEA and Hovione
Manufacturing Chemist Stand Side with Piramal Pharma Solutions

Manufacturing Chemist Stand Side with Piramal Pharma Solutions

Manufacturing Chemist Stand Side with Piramal Pharma Solutions
Manufacturing Chemist Stand Side with Almac Group

Manufacturing Chemist Stand Side with Almac Group

Manufacturing Chemist Stand Side with Almac Group

Latest Reports See all

Panthera joins the Association of Multisite Research Corporations (AMRC)

Panthera joins the Association of Multisite Research Corporations (AMRC)

Membership strengthens Panthera’s ability to collaborate across the industry, contribute to collective advocacy and help shape the future of clinical research
Terminal sterilisation versus aseptic filling: ensuring drug product safety

Terminal sterilisation versus aseptic filling: ensuring drug product safety

The sterility of drug products is critical to patient safety. Choosing between terminal sterilisation or aseptic processing to achieve this should reflect the final product’s...
US mRNA policy shift: are vaccine headwinds accelerating oncology focus?

US mRNA policy shift: are vaccine headwinds accelerating oncology focus?

With Washington’s stance on mRNA vaccines cooling, Manufacturing Chemist examines whether policy and funding signals could influence the pharmaceutical industry’s most...
Reimagining biosimilars: faster access, stronger supply, sustainable healthcare

Reimagining biosimilars: faster access, stronger supply, sustainable healthcare

Outdated development models, uneven adoption and policy barriers are holding Europe back. Dr Kevin Robinson (KSR) spoke to Matt Erick (ME), Head of Advanced Markets at Biocon...

Company News

Lonza nominates Pearl Huang to board Lonza has nominated Pearl Huang as an independent member of its Board of Directors, bringing extensive pharmaceutical and biotechnology experience and expertise in drug...
BioDuro appoints Greg Makara to lead discovery chemistry BioDuro has appointed Greg Makara, PhD, as Senior Vice President, Lead Discovery Chemistry, as the contract research, development and manufacturing organisation (CRDMO) looks...
Alcami strengthens commercial operations with appointment of Will Isom New appointment supports laboratory services sales and biologics growth
Nuclera appoints Carl Raimond as Chief Executive Officer Former Olink Proteomics president brings life-science tools leadership experience as Dr Michael Chen transitions to chief scientific and business officer
Alcami strengthens commercial operations with appointment of Will Isom as Vice President of Laboratory Services Sales Alcami, a leading contract development and manufacturing organisation (CDMO), today announced the appointment of biologics industry veteran Will Isom as Vice President of...
Codis appoints Steven Facer as Chief Commercial Officer Codis, a global contract development and manufacturing organisation (CDMO) specialising in spray drying, amorphous solid dispersions (ASDs), and advanced particle engineering,...
Qinecsa selected as technology partner for Africa’s new continent-wide medicines safety platform Qinecsa will help deliver a continent-wide medicines safety platform connecting safety data across Africa
Chiesi appoints David Khougazian as Group chief executive officer David Khougazian to lead the next phase of innovation-driven growth
See more

Upcoming events See all

About Manufacturing Chemist

Through digital, live and print products, Manufacturing Chemist informs and inspires business leaders and decision-makers around the world. With a digital-first strategy, the Group’s Editors write breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry from ingredients and packaging to regulation, retail and marketing.

Pharma 5.0 represents a paradigm shift in pharmaceutical manufacturing, paving the way for a future where medications are developed faster, customised to individual patient needs and delivered with uncompromising quality. It is not just about innovation; it is about transforming the way we think about healthcare and ultimately improving the lives of patients around the world.